http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2035181-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37a0415897590cae9808c6aaf1e4d848
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-285
filingDate 1994-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1995-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27add3c104bcc2c592d28e0964f031fd
publicationDate 1995-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2035181-C1
titleOfInvention Method of leukosis treatment
abstract FIELD: medicine. SUBSTANCE: method involves the use of the following agent containing, wt.-%: potassium arsenate 0.05-0.15; semidry or semisweet natural grape wine or whey with 3-4% sugar content - the rest. Preparation is given orally by 10 ml, 3 times per a day for 1 month (not less). Preparation stimulates organism functions, improved metabolism in cells and tissues, increases hemoglobin and erythrocyte content. EFFECT: increased effectiveness of method. 3 cl
priorityDate 1994-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID47275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452730506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449214123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56840839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516881

Total number of triples: 21.